Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

A wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...

The 2025 season of 50 free concerts features local, regional, national and international acts of every musical style.

A recent clinical trial published in the Journal of American Medical Association revealed that among individuals who are ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Bariatric surgery for severe obesity including gastric banding is under threat as rocketing indemnity insurance premiums and growing malpractice claims drive surgeons out of the field, experts warn.

Listen to Dr. Ilana Ressler explain PCOS and its significance in fertility and metabolic health on our latest episode.